New approaches to chronic hepatitis B

G Dusheiko, K Agarwal, MK Maini - New England Journal of …, 2023 - Mass Medical Soc
New Approaches to Chronic Hepatitis B | New England Journal of Medicine Skip to main content
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

[HTML][HTML] From hepatitis A to E: A critical review of viral hepatitis

D Castaneda, AJ Gonzalez, M Alomari… - World journal of …, 2021 - ncbi.nlm.nih.gov
Viral infections affecting the liver have had an important impact on humanity, as they have
led to significant morbidity and mortality in patients with acute and chronic infections. Once …

Hepatitis B virus-associated hepatocellular carcinoma

GEM Rizzo, G Cabibbo, A Craxì - Viruses, 2022 - mdpi.com
Hepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which
can cause liver disease and increased risk of hepatocellular carcinoma (HCC) in infected …

Viral hepatitis and pregnancy

NA Terrault, MT Levy, KW Cheung… - Nature reviews …, 2021 - nature.com
The management of viral hepatitis in the setting of pregnancy requires special consideration.
There are five liver-specific viruses (hepatitis A, B, C, D, E), each with unique epidemiology …

HBV-integration studies in the clinic: role in the natural history of infection

T Pollicino, G Caminiti - Viruses, 2021 - mdpi.com
Hepatitis B virus (HBV) infection is a major global health problem causing acute and chronic
liver disease that can lead to liver cirrhosis and hepatocellular carcinoma (HCC). HBV …

[HTML][HTML] The role of cGAS-STING signalling in liver diseases

R Chen, J Du, H Zhu, Q Ling - Jhep Reports, 2021 - Elsevier
The recently identified novel cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS)
activates the downstream adaptor protein stimulator of interferon genes (STING) by …

[HTML][HTML] Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines

I Sadeghian, R Heidari, S Sadeghian, MJ Raee… - European Journal of …, 2022 - Elsevier
Viral infections are a great threat to human health. Currently, there are no effective vaccines
and antiviral drugs against the majority of viral diseases, suggesting the need to develop …

Comprehensive analysis of clinically significant hepatitis B virus mutations in relation to genotype, subgenotype and geographic region

NM Araujo, SA Teles, N Spitz - Frontiers in Microbiology, 2020 - frontiersin.org
Hepatitis B virus (HBV) is a highly variable DNA virus due to its unique life cycle, which
involves an error-prone reverse transcriptase. The high substitution rate drives the evolution …

[HTML][HTML] De novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA

T Tu, B Zehnder, B Qu, S Urban - JHEP Reports, 2021 - Elsevier
Background & Aims Chronic HBV infection cannot be cured by current therapeutics owing to
their limited ability to reduce covalently closed circular (ccc) DNA levels in the livers of …

Hepatitis B virus DNA integration, chronic infections and hepatocellular carcinoma

M Bousali, G Papatheodoridis, D Paraskevis… - Microorganisms, 2021 - mdpi.com
Hepatitis B Virus (HBV) is an Old World virus with a high mutation rate, which puts its origins
in Africa alongside the origins of Homo sapiens, and is a member of the Hepadnaviridae …